Published in Cancer Res on December 01, 1976
In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci U S A (1987) 1.50
In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. Br J Cancer (1991) 0.93
Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia. Br J Clin Pharmacol (1979) 0.93
Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood (2000) 6.27
Granulopoiesis in acute myeloid leukemia and preleukemia. N Engl J Med (1971) 1.50
Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood (1993) 1.49
Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer (1984) 1.49
Granulopoiesis in neutropenic disorders. Blood (1973) 1.29
Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells. Blood (1996) 1.09
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma. Ann Intern Med (1992) 1.07
Prognostic factors and scoring systems in myelodysplastic syndromes. Haematologica (1998) 1.05
Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar). Blood (1999) 1.03
The smoldering myeloid leukemic states: clinical and biologic features. Blood (1983) 1.03
Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial. Ann Intern Med (1989) 0.96
Receptor binding and mitogenic effects of insulin and insulinlike growth factors I and II for human myeloid leukemic cells. J Cell Physiol (1987) 0.95
Immunologic selection of hemopoietic precursor cells utilizing antibody-mediated plate binding ("panning"). Blood (1985) 0.89
The preleukemic syndrome: correlation of in vitro parameters of granulopoiesis with clinical features. Am J Med (1979) 0.88
Myelodysplastic syndromes standardized response criteria: further definition. Blood (2001) 0.87
Human bone marrow and peripheral blood T lymphocyte depletion: efficacy and effects of both T cells and monocytes on growth of hematopoietic progenitors. Blood (1985) 0.87
Alteration of colony-stimulating factor output, endotoxemia, and granulopoiesis in cyclic neutropenia. Am J Hematol (1976) 0.86
Cytotoxic effects of interferon in vitro on granulocytic progenitor cells. Cancer Res (1977) 0.83
Characterization of the in vitro stromal microenvironment of human bone marrow. Int J Cell Cloning (1986) 0.83
13-cis retinoic acid treatment for myelodysplastic syndromes. J Clin Oncol (1986) 0.82
Remission maintenance therapy in acute myelogenous leukemia. West J Med (1977) 0.81
Subacute myeloid leukemia: a clinical review. Am J Med (1979) 0.79
Pure white-cell aplasia. Antibody-mediated autoimmune inhibition of granulopoiesis. N Engl J Med (1983) 0.79
Marrow adherent cell colony-stimulating activity production in acute myeloid leukemia. Blood (1978) 0.79
The effects of recombinant interleukin 2-activated natural killer cells on autologous peripheral blood hematopoietic progenitors. J Exp Med (1988) 0.79
In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders. Clin Haematol (1986) 0.79
The anemia of chronic disorders due to renal cell carcinoma: ferrokinetic and morphologic documentation of its surgical correction. Am J Med Sci (1971) 0.78
Biologic abnormalities in the myelodysplastic syndromes and myeloproliferative disorders. Nihon Ketsueki Gakkai Zasshi (1986) 0.78
Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood (1990) 0.78
Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: relation to disease progression. Leuk Res (1998) 0.78
Stromal colony-stimulating activity production and myeloid colony-forming cells in human hemopoietic and nonhemopoietic bone marrow. Blood (1981) 0.77
Multivariate analysis of factors associated with outcome of treatment for adults with acute myelogenous leukemia. Cancer (1984) 0.77
The chronic idiopathic neutropenia syndrome: correlation of clinical features with in vitro parameters of granulocytopoiesis. Blood (1980) 0.77
Functional interactions between colony-stimulating factors and the insulin family hormones for human myeloid leukemic cells. Cancer Res (1990) 0.77
Remission of acute myelogenous leukemia complicating Waldenström macroglobulinemia. West J Med (1978) 0.75
Clinical utility of in vitro evaluation of granulopoiesis. Annu Rev Med (1974) 0.75
An apology. J Hematother Stem Cell Res (1999) 0.75
Effects of granulocyte colony-stimulating factor therapy on in vitro hemopoiesis in myelodysplastic syndromes. Leukemia (1995) 0.75
Response of agranulocytosis to prolonged antithymocyte globulin therapy. J Pediatr (1983) 0.75
Correlative patterns of leukocyte counts at presentation and relapse in acute myelogenous leukemia. Acta Haematol (1986) 0.75
Lithium treatment in adults with acute myeloid leukemia receiving chemotherapy. Med Pediatr Oncol (1984) 0.75
Therapy of hematopoietic disorders with recombinant colony-stimulating factors. Adv Pharmacol (1992) 0.75
NCCN Practice Guidelines for Chronic Myelogenous Leukemia. Oncology (Williston Park) (2000) 0.75
Splenic granulocytopoiesis and production of colony-stimulating activity in lymphoma and leukemia. Blood (1981) 0.75
Human spleen cell generation of factors stimulating human pluripotent stem cell, erythroid, and myeloid progenitor cell growth. Blood (1985) 0.75
Clinical relevance of in vitro study of granulocytopoiesis. Scand J Haematol (1980) 0.75
Bone marrow cell modulation and inhibition of myelopoiesis by large granular lymphocytes and natural killer cells. Int J Cell Cloning (1990) 0.75
Role of intracellular degradation of epidermal growth factor in mitogenesis. Exp Cell Res (1982) 0.75
Modulation of apoptosis in human myeloid leukemic cells by GM-CSF. Exp Hematol (1995) 0.75
The use of colony stimulating factors in clinical bone marrow transplantation. Curr Opin Immunol (1992) 0.75
Effects of lithium chloride on human and murine marrow myeloid colony formation and colony stimulating activity. Adv Exp Med Biol (1980) 0.75
Murine granulopoiesis after fractionated total lymphoid irradiation and allogeneic bone marrow transplantation. Exp Hematol (1983) 0.75